Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Decoding the m6A epitranscriptomic landscape for biotechnological applications using a direct RNA sequencing approach
Chuwei Liu, Heng Liang, Arabella Wan, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Redox regulation: mechanisms, biology and therapeutic targets in diseases
Bowen Li, Hui Ming, Siyuan Qin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 6
Mechanisms and technologies in cancer epigenetics
Zaki A. Sherif, Olorunseun O. Ogunwobi, Habtom W. Ressom
Frontiers in Oncology (2025) Vol. 14
Open Access
Insights into the Molecular Mechanisms and Nanoparticle-Based Therapies for Gastric Cancer: A review
Smarika Chauhan, Eswar Marcharla, Sneha Hariharan, et al.
Results in Engineering (2025), pp. 104238-104238
Open Access
Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access
eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m6A modification
Qianying Ouyang, Jiajia Cui, Yang Wang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
DNA Methylation in Periodontal Disease: A Focus on Folate, Folic Acid, Mitochondria, and Dietary Intervention
Elżbieta Pawłowska, Joanna Szczepańska, Marcin Derwich, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3225-3225
Open Access
Epitherapeutics: The Next Frontier in Targeted Precision Therapy
Ananya Asudani, Michael K. Choi
Inside Precision Medicine (2025) Vol. 12, Iss. 2, pp. 22-24, 26, 27, 28
Closed Access
Novel Epigenetics Control (EpC) Nanocarrier for Cancer Therapy Through Dual-Targeting Approach to DNA Methyltransferase and Ten-Eleven Translocation Enzymes
R. Mitsuhashi, Kiyoshi Sato, Hiroyoshi Kawakami
Epigenomes (2025) Vol. 9, Iss. 1, pp. 6-6
Open Access
Promoter Hypermethylation of the BRCA1 Gene as a Novel Biomarker for Prostate Cancer
Mohammed A Saleem, Mustafa S Mustafa
Cureus (2024)
Open Access | Times Cited: 1
Acetylation of Histone H3 in Cancer Progression and Prognosis
Paulina Miziak, Marzena Baran, Lidia Borkiewicz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10982-10982
Open Access | Times Cited: 1
State of the art CRISPR-based strategies for cancer diagnostics and treatment
Emma Di Carlo, Carlo Sorrentino
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Epigenetic contributions to cancer: Exploring the role of glycation reactions
Hamda Khan, Zeeshan Rafi, Mohd Yasir Khan, et al.
International review of cell and molecular biology (2024), pp. 143-193
Closed Access
Identification of Poliovirus Receptor-like 3 Protein as a Prognostic Factor in Triple-Negative Breast Cancer
Gian Marco Leone, Katia Mangano, S Caponnetto, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1299-1299
Open Access
Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies
M M Rahman, Khadija Akter, Kazi Rejvee Ahmed, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2777-2777
Open Access
Collateral lethality: A unique type of synthetic lethality in cancers
Zichen Zhao, Lingling Zhu, Yu Luo, et al.
Pharmacology & Therapeutics (2024) Vol. 265, pp. 108755-108755
Closed Access
Epigenetic maneuvering: an emerging strategy for mycobacterial intracellular survival
Prakruti R. Singh, Valakunja Nagaraja
Trends in Microbiology (2024)
Closed Access
Exploring host epigenetic enzymes as targeted therapies for visceral leishmaniasis: in silico design and in vitro efficacy of KDM6B and ASH1L inhibitors
Mukul Dutta, Tooba Qamar, Unnati Kushavah, et al.
Molecular Diversity (2024)
Closed Access
Page 1

Scroll to top